How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Accelerating Kids’ Access to Care Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Lowering Drug Costs for American Families Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Fentanyl Crisis Research and Evaluation Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
SMART Prices Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Accelerating Kids’ Access to Care Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Accelerating Kids’ Access to Care Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Lowering Drug Costs for American Families Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Fentanyl Crisis Research and Evaluation Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
SMART Prices Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Accelerating Kids’ Access to Care Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Steel Industry Preservation Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 FDA Neurology Drug Program SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
SUPPORT Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 FDA Neurology Drug Program SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 FDA Neurology Drug Program SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Expressing support for the protection of Medicare part D's six protected classes.
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Expressing support for the protection of Medicare part D's six protected classes.
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Resiliency for Ranching and Natural Conservation Health Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 FDA Neurology Drug Program SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Recovering America’s Wildlife Act of 2022
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 FDA Neurology Drug Program SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 FDA Neurology Drug Program SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act FDA Neuroscience Center of Excellence S.3427, The Neuroscience Center of Excellence Act of 2021
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program
Inflation Reduction Act of 2022
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees
Inflation Reduction Act of 2022
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act FDA Neuroscience Center of Excellence S.3427, The Neuroscience Center of Excellence Act of 2021
Inflation Reduction Act of 2022
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program
Cures 2.0 Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Cures 2.0 Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program
Cures 2.0 Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees
Cures 2.0 Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act FDA Neuroscience Center of Excellence S.3427, The Neuroscience Center of Excellence Act of 2021
Expressing support for the protection of Medicare part D's six protected classes.
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Seniors Prescription Drug Relief Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act FDA Neuroscience Center of Excellence S.3427, The Neuroscience Center of Excellence Act of 2021
Seniors Prescription Drug Relief Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Seniors Prescription Drug Relief Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program
Seniors Prescription Drug Relief Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act FDA Neuroscience Center of Excellence S.3427, The Neuroscience Center of Excellence Act of 2021
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021
Reduced Costs and Continued Cures Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act
Inflation Reduction Act of 2022
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021
Seniors Prescription Drug Relief Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act
Seniors Prescription Drug Relief Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021
Neuroscience Center of Excellence Act of 2021
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part B drug coverage and payment/international pricing index model Medicare Part D Negotiation/Non-Interference Repeal Bills Price Transparency legislation Medicare Part D Out-of-Pocket Cap Proposal Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Pharmaceutical Supply Chain Notice of Benefit and Payment Parameters Medicare SKilled Nursing Facility Proposed Rule
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Pharmaceutical Supply Chain Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing
Elijah E. Cummings Lower Drug Costs Now Act
Client: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) · Firm: SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Discussions regarding protected classes reform, Medicare Part D Part B drug coverage and Payment reform; international pricing index model Medicare Part D Negotiation/Non-Interference Repeal Bills Price Transparency legislation Medicare Part D Out-of-Pocket Cap Proposal Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes
2023 · fourth_quarter · Q4
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 FDA Neurology Drug Program SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services Accelerating Kids Access to Care Act (S. 2372, H.R. 4758) The Modernizing and Ensuring PBM Accountability Act (no bill # yet) Medicaid Drug Rebate Proposed Rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing H.R.5237, The Reduced Cost and Continued Cures Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Inflation Reduction Act Medicare Part D 6 Protected Classes Executive Order on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program H.Res.1390, Expressing support for the protected class
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Inflation Reduction Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees FDA Neurology Drug Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021 Prescription Drug User Fees
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing S. 2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Cost and Continued Cures Act H.R.6000, the CURES 2.0 Act H.R.5376, The Build Back Better Act FDA Neuroscience Center of Excellence S.3427, The Neuroscience Center of Excellence Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act H.R.5376, The Build Back Better Act S.3427, The Neuroscience Center of Excellence Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence S.2327, Seniors Prescription Drug Relief Act H.R.5237, The Reduced Costs and Continued Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing FDA Neuroscience Center of Excellence
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Pharmaceutical Supply Chain Notice of Benefit and Payment Parameters Proposed Medicaid Regulation Executive Orders on Drug Pricing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D Negotiation/Non-Interference Repeal Bills Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes Medicare Part D Redesign proposal Pharmaceutical Supply Chain Notice of Benefit and Payment Parameters Medicare SKilled Nursing Facility Proposed Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medicare Part B drug coverage and payment/international pricing index model Medicare Part D Negotiation/Non-Interference Repeal Bills Price Transparency legislation Medicare Part D Out-of-Pocket Cap Proposal Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Discussions regarding protected classes reform, Medicare Part D Part B drug coverage and Payment reform; international pricing index model Medicare Part D Negotiation/Non-Interference Repeal Bills Price Transparency legislation Medicare Part D Out-of-Pocket Cap Proposal Senate Finance Prescription Drug Pricing Reduction Act H.R.3-The Lower Drug Costs Now Act Medicare Part D 6 Protected Classes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Discussions regarding protected classes reform, Medicare Part D Part B drug coverage and Payment reform; international pricing index model Medicare Part D Negotiation/Non-Interference Repeal Bills Price Transparency legislation (STAR Act-House) HHS OIG Rebate Reform Proposed Rule Medicare Part D Out-of-Pocket Cap Proposal Senate Finance Prescription Drug Pricing Reduction Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Discussions regarding protected classes reform, Medicare Part D Part B drug coverage and Payment reform; international pricing index model Medicare Part D Negotiation/Non-Interference Repeal Bills Price Transparency legislation (STAR Act-House) President's Drug Pricing Blueprint HHS OIG Rebate Reform Proposed Rule Medicare Part D Out-of-Pocket Cap Proposal
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE